histidine has been researched along with Parkinsonian Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funayama, M; Hattori, N; Li, Y; Matsuura, E; Nishioka, K; Takanashi, M; Takashima, H; Tsuyama, S; Yoshino, H | 1 |
Bonifati, V; Farrer, MJ; Ferreira, JJ; Griffith, A; Haugarvoll, K; Kachergus, J; Latsoudis, H; Lin, CH; Plaitakis, A; Ross, OA; Sampaio, C; Spanaki, C; Wu, RM; Zabetian, CP | 1 |
Birk Møller, L; Diepold, K; Güttler, F; Hougaard, P; Romstad, A; Rostasy, K; Schütz, B; Wilken, B | 1 |
3 other study(ies) available for histidine and Parkinsonian Disorders
Article | Year |
---|---|
Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations.
Topics: Aged; alpha-Synuclein; Astrocytes; Autopsy; DNA-Binding Proteins; Female; Gene Expression Regulation; Histidine; Homozygote; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Neurodegenerative Diseases; Parkinsonian Disorders; Proline; Protein Aggregation, Pathological; Substantia Nigra; tau Proteins | 2018 |
Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism.
Topics: Adult; Arginine; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinsonian Disorders; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases | 2009 |
Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections.
Topics: Animals; Antiparkinson Agents; Central Nervous System Viral Diseases; Child, Preschool; DNA Mutational Analysis; Female; Histidine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Mice; Mutation; Parkinsonian Disorders; Rats; Treatment Outcome; Tyrosine; Tyrosine 3-Monooxygenase | 2005 |